Novozymes B Announces Leadership Change as Jacob Vishof Paulsen Steps Down
Novozymes B’s Executive Vice President Jacob Vishof Paulsen will leave his position on March 31, 2025, to assume a new role outside the company.
One minute to read
Novonesis (Novozymes) B
Novonesis B Navigates Volatile Market with Stabilizing Trends Amidst Price Fluctuations
Novonesis B, a Danish asset, has experienced significant price volatility, with its value oscillating between a 52-week high of 485.9 DKK and a low of 370.4 DKK, presenting a complex investment opportunity.
One minute to read